The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Early toxicity in a randomized trial of high dose-rate (HDR) brachytherapy as monotherapy for low- and intermediate-risk prostate cancer.
 
Gerard Morton
Honoraria - Abbvie; AstraZeneca
 
Hans T. Chung
Honoraria - Sanofi
 
Merrylee McGuffin
No Relationships to Disclose
 
Liying Zhang
No Relationships to Disclose
 
Ananth Ravi
Research Funding - Philips Healthcare
 
Laura D'Alimonte
No Relationships to Disclose
 
Andrew Loblaw
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb (I); Elekta; GlaxoSmithKline (I); Janssen Oncology; Merck (I); Novartis (I); Paladin; Roche (I); Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Atlas Global Healthcare; Bristol-Myers Squibb (I); GlaxoSmithKline (I); Janssen Oncology; Merck (I); Novartis (I); Roche (I); Sanofi
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Janssen Oncology